SMTL ID : 7o2v.1

AURORA KINASE A IN COMPLEX WITH THE AUR-A/PDK1 INHIBITOR VI8

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.10 Å

Oligo State

monomer

Ligands

1 x V0K: 1-[[3,4-bis(fluoranyl)phenyl]methyl]-~{N}-[(1~{R})-2-[[(3~{E})-3-(1~{H}-imidazol-5-ylmethylidene)-2-oxidanylidene-1~{H}-indol-5-yl]amino]-2-oxidanylidene-1-phenyl-ethyl]-6-methyl-2-oxidanylidene-pyridine-3-carboxamide(Non-covalent)

V0K.1: 24 residues within 4Å: Chain A: L.35, G.36, K.37, G.38, K.39, G.41, N.42, V.43, A.56, K.58, L.106, E.107, Y.108, A.109, G.112, T.113, R.116, D.152, K.154, E.156, N.157, L.159, F.171, G.187 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:K.39, A:V.43, A:V.43, A:K.58, A:K.154, A:L.159, A:L.159 Hydrogen bonds: A:A.109, A:T.113

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Sestito, S. et al., Development of potent dual PDK1/AurA kinase inhibitors for cancer therapy: Lead-optimization, structural insights, and ADME-Tox profile. Eur.J.Med.Chem. (2021)

Release Date

2021-10-20

Peptides

Aurora kinase A: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Aurora kinase A